{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:34:10Z","timestamp":1789356850056,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.neurol.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T08:41:30Z","timestamp":1466671290000},"page":"709-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neurodegeneration in tauopathies and synucleinopathies"],"prefix":"10.1016","volume":"172","author":[{"given":"C.","family":"Foguem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kamsu-Foguem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.neurol.2016.05.002_bib0110","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.arr.2010.08.006","article-title":"Ageing and neurodegenerative diseases","volume":"9","author":"Hung","year":"2010","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.neurol.2016.05.002_bib0115","first-page":"407","article-title":"Neurodegenerative diseases","volume":"163","author":"Checkoway","year":"2011","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.neurol.2016.05.002_bib0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2478\/v10136-011-0013-4","article-title":"Neurodegenerative diseases and neuroprotection: current views and prospects","volume":"9","author":"Nieoullon","year":"2011","journal-title":"J Appl Biomed"},{"issue":"6","key":"10.1016\/j.neurol.2016.05.002_bib0125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease","volume":"115","author":"Bertram","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.neurol.2016.05.002_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurol.2016.05.002_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2015.07.003","article-title":"Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies","author":"Bourdenx","year":"2015","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1016\/j.neurol.2016.05.002_bib0140","first-page":"244","article-title":"Tauopathies: recent insights into old diseases","volume":"43","author":"Delacourte","year":"2005","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.neurol.2016.05.002_bib0145","series-title":"Basic Neurochemistry","first-page":"829","article-title":"Synucleinopathies and tauopathies","author":"Goedert","year":"2012"},{"issue":"11","key":"10.1016\/j.neurol.2016.05.002_bib0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jalz.2014.12.008","article-title":"Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia","volume":"11","author":"Adams","year":"2015","journal-title":"Alzheimers Demen"},{"issue":"Pt A","key":"10.1016\/j.neurol.2016.05.002_bib0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2014.08.026","article-title":"Ghrelin: a link between ageing, metabolism and neurodegenerative disorders","volume":"72","author":"Stoyanova","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.neurol.2016.05.002_bib0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.taap.2011.05.006","article-title":"Association between environmental exposure to pesticides and neurodegenerative diseases","volume":"256","author":"Parr\u00f3n","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neurol.2016.05.002_bib0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2012.01.038","article-title":"Epigenetic programming of neurodegenerative diseases by an adverse environment","volume":"1444","author":"Babenko","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2016.05.002_bib0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2014.09.008","article-title":"The role of the immune system in neurodegenerative disorders: adaptive or maladaptive?","volume":"1617","author":"Doty","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2016.05.002_bib0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2013.01.008","article-title":"Consortium. The Alzheimer's disease neuroimaging initiative, and the Alzheimer's Disease Genetics Consortium. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease","volume":"10","author":"Sherva","year":"2014","journal-title":"Alzheimer Demen"},{"key":"10.1016\/j.neurol.2016.05.002_bib0180","series-title":"Encyclopedia of Mental Health","first-page":"58","article-title":"Alzheimer's disease: an overview","author":"Dunne","year":"2016"},{"key":"10.1016\/j.neurol.2016.05.002_bib0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2016.05.002_bib0190","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S1353-8020(13)70016-6","article-title":"Staged pathology in Parkinson's disease","volume":"20","author":"Alafuzoff","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.neurol.2016.05.002_bib0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2016.05.002_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jns.2015.11.004","article-title":"123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias","volume":"359","author":"Brigo","year":"2015","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.neurol.2016.05.002_bib0205","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2016.05.002_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.09.020","article-title":"The innate and adaptive immunological aspects in neurodegenerative diseases","volume":"269","author":"Rodrigues","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2016.05.002_bib0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.eurger.2015.02.011","article-title":"Knowledge-based modelling applied to synucleinopathies","volume":"6","author":"Kamsu-Foguem","year":"2015","journal-title":"European Geriatric Medicine"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378715300461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378715300461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T22:25:32Z","timestamp":1536618332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378715300461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0035378715300461"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.05.002","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodegeneration in tauopathies and synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}